REFERENCES
- Hopefl A. The cardiac risks of noncardiac medications: Should you make formulary changes?. P&T 2002; 27(9)432–433, Available: www.formkit.com/ptjournal/fulltext/27/9/PTJ2709432.pdf
- Martell B. A., Arnsten J. H., Krantz M. J., Gourevitch M. N. Impact of methadone treatment on cardiac repolarization and conduction in opioid users. American Journal of Cardiology 2005; 95(7)915–918, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pearson E. C., Woosley R. L. QT prolongation and torsades de pointes among methadone users: Reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Safety 2005; 14: 1–7, [CROSSREF], [CSA]